Skip to main content
AAN.com
Research Article
July 14, 2021
Letter to the Editor

Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia

August 31, 2021 issue
97 (9) e922-e929

Abstract

Objective

To test the hypothesis that higher level of cognitive activity predicts older age at dementia onset in Alzheimer disease (AD) dementia.

Methods

As part of a longitudinal cohort study, 1,903 older persons without dementia at enrollment reported their frequency of participation in cognitively stimulating activities. They had annual clinical evaluations to diagnose dementia and AD, and the deceased underwent neuropathologic examination. In analyses, we assessed the relation of baseline cognitive activity to age at diagnosis of incident AD dementia and to postmortem markers of AD and other dementias.

Results

During a mean of 6.8 years of follow-up, 457 individuals were diagnosed with incident AD at a mean age of 88.6 (SD 6.4, range 64.1–106.5) years. In an extended accelerated failure time model, higher level of baseline cognitive activity (mean 3.2, SD 0.7) was associated with older age at AD dementia onset (estimate 0.026; 95% confidence interval 0.013–0.039). Low cognitive activity (score 2.1, 10th percentile) was associated with a mean onset age of 88.6 years compared to a mean onset age of 93.6 years associated with high cognitive activity (score 4.0, 90th percentile). Results were comparable in subsequent analyses that adjusted for potentially confounding factors. In 695 participants who died and underwent a neuropathologic examination, cognitive activity was unrelated to postmortem markers of AD and other dementias.

Conclusion

A cognitively active lifestyle in old age may delay the onset of dementia in AD by as much as 5 years.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Scarmeas N, Levy G, Tng MX, Manly J, Stern Y. Influence of leisure activity on the incidnece of Alzheimer'sdisease. Neurology. 2001;57(12):2236-2242.
2.
Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA. 2002;287(6):742-748.
3.
Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol. 2002;155(12):1081-1087.
4.
Wilson RS, Bennett DA, Bienias JL, et al. Cognitive activity and incidnet AD in a population-based sample of older persons. Neurology. 2002;59(12):1910-1914.
5.
Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003;348(25):2508-2516.
6.
Karp A, Paillard-Borg S, Wang HX, Silverstein M, Winblad B, Fratiglioni L. Mental, physical and social components in leisure activities contribute to decrease dementia risk. Dement Geriatr Cogn Disord. 2006;21(2):65-73.
7.
Hughes TF, Chang CC, Vander Bilt J, Ganguli M. Engagement in reading and hobbies and risk of incident dementia: the MoVies project. Am J Alzheimers Dis Other Demen. 2010;25(5):432-438.
8.
Lee ATC, Richards M, Chan WC, Chiu HFK, Lee RSY, Lam LCW. Association of daily intellectual activities with lower risk of incident dementia among older Chinese adults. JAMA Psychiatry. 2018;75(7):697-703.
9.
Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. Relation of cognitive activity to risk of developing Alzheimer's disease. Neurology. 2007;69(20):1911-1920.
10.
Hultsch DF, Hertzog C, Small BJ, Dixon RA. Use it or lose it: engaged lifestyle as a buffer against cognitive aging? Psychol Aging. 1999;14(2):245-263.
11.
Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013;81(4):314-321.
12.
Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11):1006-1012.
13.
Park DC, Bischof GN. The aging mind: neuroplasticity in response to cognitive training. Dialogues Clin Neurosci. 2013;15(1):109-119.
14.
Gatz M, Prescott CA, Pedersen NL. Lifestyle risk and delaying factors. Alzheimer Dis Assoc Disord. 2006;20(3 suppl 2):S84-S88.
15.
Moritz DJ, Petitti DB. Association of education with reported age of onset and severity of Alzheimer's disease at presentation: implications for the use of clinical samples. Am J Epidemiol. 1993;137(4):456-462.
16.
Bowler JV, Munoz DG, Merskey H, Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1998;65(2):184-190.
17.
Del Ser T, Hachinski V, Merskey H, Munoz DG. An autopsy-verified study of the effect of education on degenerative dementia. Brain. 1999;122(pt 12):2309-2319.
18.
Roe CM, Xiong CX, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer's disease. Arch Neurol. 2008;65(1):108-111.
19.
Lupton MK, Stahl D, Archer N, et al. Education, occupation and retirement age effects on the age of onset of Alzheimer's disease. Int J Geriatr Psychiatry. 2010;25(1):30-36.
20.
Bennett DA, Buchman AS, Boyle PA, Barnes LL, Schneider JA, Wilson RS. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018;64(s1):S161-S189.
21.
Wilson RS, Krueger KR, Arnold SE, et al. Loneliness and risk of Alzheimer's disease. Arch Gen Psychiatry. 2007;64(2):234-240.
22.
de Jong-Gierveld J. Developing and testing a model of loneliness. J Pers Soc Psychol. 1987;53(1):119-128.
23.
McKhann G, Drachman D, Folstein M, Katzman M, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
24.
Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205.
25.
Bennett DA, Schneider JA, Aggarwal NT, et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27(3):169-176.
26.
Wilson RS, Boyle PA, Yang J, James BD, Bennett DA. Early life instruction in foreign language and music and incidence of mild cognitive impairment. Neuropsychology. 2015;29(2):292-302.
27.
Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66(2):200-208.
28.
National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997;18(4 suppl):S1-S2.
29.
Jackson CH. Flexsurv: a platform for parametric survey modeling in R. J Stat Softw. 2016;70(8):i08.
30.
Cox C, Chu H, Schneider MF, Munoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med. 2007;26(23):4352-4374.
31.
Lamarca R, Alonso J, Gomez G, Munoz A. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci. 1998;53(5):M337-M343.
32.
Wilson RS, Bennett DA, Beckett LA, et al. Cognitive activity in older persons from a geographically defined population. J Gerontol Psychol Sci Soc Sci. 1999;54(3):P155-P160.
33.
Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271(13):1004-1010.
34.
Mazure CM, Swendsen J. Sex differences in Alzheimer's disease and other dementias. Lancet Neurol. 2016;15(5):451-452.
35.
Wilson RS, Yu L, Lamar M, Schneider JA, Boyle PA, Bennett DA. Education and cognitive reserve in old age. Neurology. 2019;92(10):e1041-e1050.
36.
Wilson RS, Segawa E, Boyle PA, Bennett DA. Influence of late-life cognitive activity on cognitive health. Neurology. 2012;78(15):1123-1129.
37.
Arfanakis K, Wilson RS, Barth CM, et al. Cognitive activity, cognitive function, and brain diffusion characteristics in old age. Brain Imaging Behave. 2016;10(2):455-463.
38.
Draganski B, Gaser C, Kempermann G, et al. Temporal and spatial dynamics of brain structure changes during extensive learning. J Neurosci. 2006;26(23):6314-6317.
39.
Woollett K, Maguire EA. Acquiring “the knowledge” of London's layout drives structural brain changes. Curr Biol. 2011;21(24):2109-2114.
40.
Schmidt-Wilcke T, Rosengarth K, Luerding R, Bogdahn U, Greenlee MW. Distinct patterns of functional and structural neuroplasticity associated with learning Morse code. Neuroimage. 2010;51(3):1234-1241.
41.
Brookmeyer R, Gray S, Kawas CH. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):137-1342.
42.
Zissimopoulos J, Crimmins E, Clair StP. The value of delaying Alzheimer's disease onset. Forum Health Econ Pol. 2014;18(1):25-39.
43.
Brookmeyer R, Abdalia N, Kawas CH, Corrada MM. Forecasting the prevalence of pre-clinical Alzheimer's disease in the United States. Alzheimer’s Dement. 2018;14(2):121-129.
44.
Brookmeyer R, Johnson E, Ziegler-Graham A, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186-191.
45.
Barnes DE, Yaffe K. The projected impact of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-828.
Letters to the Editor
6 December 2021
Reader Response: Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia
Piero Andrei Rosas-Ortega, Medical Student| Cayetano Heredia Peruvian University
Felipe Ernesto Terpin-Ayvar, Medical Student| Cayetano Heredia Peruvian University

As medical students, we were eager to provide some comments on this neurologic study.1 The authors discuss the appearance of dementia in Alzheimer's disease and cognitive activity in old age. This topic is of special interest to us.

A recent article by Garcia-Gorro et. al. mentions that a cognitively active lifestyle confers physical and intellectual benefits in multiple neurodegenerative diseases.2 It is proposed that Huntington's disease can provide a model to study the effects and neural mechanisms of cognitive engagement in neurodegeneration. The authors suggest that it may promote brain maintenance by modulating the executive control resting-state network and conferring protection against neurodegeneration, which results in a delayed onset of symptoms and improved performance in executive functions.

The study by Hartman and colleagues examines physical activity, sedentary behavior, and characteristics of ambulatory and community-dwelling in patients with dementia.3 Patients were compared to cognitively healthy age-, sex-, and weight-matched controls. The study concludes that dementia patients have elevated sedentary behavior and perform less physical activity than cognitively healthy controls.

To conclude, there is an evident relationship between these concepts. Furthermore, the inclusion of cognitive activity as therapy and its impact on cognitive degeneration are promising factors to be studied.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Wilson RS, Wang T, Yu L, Grodstein F, Bennett DA, Boyle PA. Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia. Neurology. 2021;97(9):e922-e929. doi:10.1212/WNL.0000000000012388
  2. Garcia-Gorro C, Garau-Rolandi M, Escrichs A, et al. An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease. Neuropsychologia. 2019;122:116-124. doi:10.1016/j.neuropsychologia.2018.10.017
  3. Hartman YAW, Karssemeijer EGA, van Diepen LAM, Olde Rikkert MGM, Thijssen DHJ. Dementia Patients Are More Sedentary and Less Physically Active than Age- and Sex-Matched Cognitively Healthy Older Adults. Dement Geriatr Cogn Disord. 2018;46(1-2):81-89. doi:10.1159/000491995
24 September 2021
Author Response: Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia
Robert S. Wilson, Professor of Neuropsychology| Rush University Medical Center

We appreciate the interest in our research.1 In the cohort study of older persons who developed incident Alzheimer's disease (AD), we found that a lower level of cognitive activity was associated with earlier age of dementia onset.1 According to the reverse-causality hypothesis, a low level of cognitive activity is not a risk factor for AD but an early sign of the disease. As a test of this hypothesis, we computed the correlations of cognitive activity with markers of AD at the time of study enrollment, as well as related dementias during a postmortem neuropathological examination. These correlations were not significant, which we concluded provided no support for the reverse-causality hypothesis.

Dr. Krauss notes in their comment that the study fails to fully disprove the reverse causality hypothesis, due to possible changes in brain structure or function that are not captured on postmortem evaluation. We agree that our study does not disprove the reverse-causality hypothesis. However, observations in this research and previous studies that measurements of cognitive activity are related to risk of dementia but not to the neuropathologies thought to underlie dementia is certainly inconsistent with the reverse-causality hypothesis.2,3 Further, one may question the scientific value of a hypothesis if it depends on disease markers that cannot be specified and are apparently unrelated to neuropathologic markers traditionally associated with AD and related dementias.

Disclosure

The author reports no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Wilson RS, Wang T, Yu L, Grodstein F, Bennett DA, Boyle PA. Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia. Neurology. 2021;97(9):e922-e929. doi:10.1212/WNL.0000000000012388
  2. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007;69(20):1911-1920. doi:10.1212/01.wnl.0000271087.67782.cb
  3. Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013;81(4):314-321. doi:10.1212/WNL.0b013e31829c5e8a
25 July 2021
Reader Response: Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia
Howard Krauss, Neuro-ophthalmologist| Pacific Neuroscience Institute

The authors of this study note that postmortem markers of Alzheimer Disease (AD) and other dementias may be distinct from the self-report measure of cognitive activity, which they state provides no support for the reverse causality hypothesis.1 The authors suggest that cognitive activities may lead to changes in brain structure and function that could enhance cognitive reserve. Isn't it just as likely that there are features of brain structure or function that have not been discerned in postmortem evaluation, thus failing to fully disprove the reverse causality hypothesis?

Disclosure

The author reports no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Wilson RS, Wang T, Yu L, Grodstein F, Bennett DA, Boyle PA. Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia [published online ahead of print, 2021 Jul 14]. Neurology. 2021;10.1212/WNL.0000000000012388.

Information & Authors

Information

Published In

Neurology®
Volume 97Number 9August 31, 2021
Pages: e922-e929
PubMed: 34261788

Publication History

Received: January 28, 2021
Accepted: May 27, 2021
Published online: July 14, 2021
Published in issue: August 31, 2021

Permissions

Request permissions for this article.

Disclosure

Robert S. Wilson, Tianhao Wang, Lei Yu, Fran Grodstein, David A. Bennett, and Patricia A. Boyle have no disclosures to report. Go to Neurology.org/N for full disclosures.

Study Funding

This study was supported by NIA grants R01AG17917 and R01AG34374.

Authors

Affiliations & Disclosures

From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
(1) Aging, Neuropsychology, and Cognition, Consulting Editor, 2004-present; (2) Psychology and Aging, Consulting Editor, 2007-present; (3) Neuropsychology, Consulting Editor, 2014-present.
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1) NIH/NIA R01AG17917, Co-I, 2001-2014; (2) NIH/NIA P30AG10161, Co-I, 1991-2014; (3) NIH/NIA R01AG34374, Co-I, 2008-2014; (4) NIH/NIA R01AG15819, Co-I, 1998-2014.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tianhao Wang, PhD
From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
R01AG053446 (PI: Beeri; Role: Co-I) 9/1/16-5/31/21 National Institute on Aging Peripheral and brain levels of advanced glycation end products (AGEs) and incident Alzheimer’s disease and neuropathology The proposed study will test the hypothesis that brain AGEs are related to impaired cognition in older adults through an association with AD and other neuropathologies, and that dietary and serum AGEs are related to brain AGEs. R01AG034374 (PI: Boyle; Role: Co-I) 8/15/09-3/31/20 National Institute on Aging Characterizing the Behavior Profile of Healthy Cognitive Aging The major goal of this study is to apply novel statistical approaches to longitudinal cognitive and neuropathologic data to identify the profile of healthy cognitive aging and distinguish it from the very earliest manifestation of pathologic cognitive aging. RF1AG015819 (PI: Bennett; Role: Co-I) 7/1/98-6/30/19 National Institute on Aging Risk Factors, Pathology, and Clinical Expressions of AD The overall goal of the proposal is to identify brain proteins and proteoforms linking AD risk genes to AD endophenotypes, i.e., AD pathology and cognitive decline. R56AG060757 (MPI: Jin/Wingo/Qin; Role: Co-I) 9/30/18-8/31/19 National Institute on Aging Computational Prediction and Functional Validation of Novel Risk Loci in Alzheimer’s Disease The central goal of this proposal is to identify new AD genetic associations using a novel machine learning approach that offers an innovative alternative to traditional genetic association studies. R56AG062256 (MPI: Jin/Wingo/Qin; Role: Co-I) 9/30/18-8/31/19 National Institute on Aging Computational Prediction and Functional Validation of Novel Epigenetic Risk Loci in Alzheimer’s Disease Our proposal aims to find new genetic causes of AD by employing cutting-edge computational approaches, followed by experimental validation. We propose a 2-stage (discovery/replication) study using a unique dataset of human postmortem brains from the Rush Memory and Aging Project (MAP) and Religious Orders Study (ROS). Simultaneously, we propose functional studies in model systems to determine whether the selective identified loci could influence AD pathogenesis.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Lei Yu, PhD
From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
Texas Alzheimer's Research and Care Consortium Scientific Review Panel
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
the FINRA (Financial Industry Regulatory Authority) Investor Education Foundation
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIA, R01AG053446, biostatistician, 2016-2021 NIA, RF1AG015819, biostatistician, 1998-2019 NIA, R01AG017917, biostatistician, 2001-2019 NIA, RF1AG036042, biostatistician, 2009-2021 NIA, U01AG046152, biostatistician, 2013-2018 NIA, R01AG054058, biostatistician, 2016-2021 NIA, R01AG034374, biostatistician, 2009-2020 NIA, R01AG033678, biostatistician, 2009-2020 NIH, R01DK099269, biostatistician, 2014-2018 NIA, R01AG052488, biostatistician, 2017-2022 NIA, R01AG050631, biostatistician, 2016-2021 NIA, RF1AG048056, biostatistician, 2014-2019
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Francine Grodstein, PhD
From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Menopause, the Journal of the North American Menopause Society, Statistical Editor, since 2000
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIA R01AG15819, R01AG17917, R01AG36042 co-investigator, 2020-present NIDDK R01, co-investigator, 2018-2022
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
California Walnut Commission
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
David A. Bennett, MD
From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
(1) Vigorous Minds, Scientific Advisory Board (3) EABs: India Institute of Science; MCSA; Columbia ADRC; CCNA; CIMA-Q, WFU, Emory, MODEL-AD, REGARDS (4) DMCs: HRS, MIDUS (5) National Advisory Council on Aging
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
(1) Neurology, Editorial Board; (2) Current Alzheimer Research, Editorial Board; (3) Neuroepidemiology, Editorial Board (4) Journal of the Prevention of Alzheimer's Disease, Editorial Board (5) Journal of Alzheimer's Disese (5) Journal of Alzheimer's Disease, Editorial Board (6) Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Editorial Board
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Consultant, Origent Data Sciences NIH SBIR grant
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Biogen - funding for analyses of our own data Neurovision - amyloid eye imaging
Research Support, Government Entities:
1.
NIH: P30AG10161, PI; R01AG15819, PI; R01AG17917, PI; R01AG36042, MPI; R01AG54058, PI; U01AG61356, MPI; R01AG52476, MPI,
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Patricia A. Boyle, PhD
From the Rush Alzheimer's Disease Center (R.S.W., T.W., L.Y., F.G., D.A.B., P.A.B.), Department of Neurological Sciences (R.S.W., T.W., L.Y., F.G., D.A.B.), and Department of Psychiatry and Behavioral Sciences (R.S.W., P.A.B.), Rush University Medical Center, Chicago, IL.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1) NIH/NIA R01AG034374, PI; (2) NIH/NIA R01AG033678, PI
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Wilson [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Improv as cognitive activity, Frontiers in Aging Neuroscience, 17, (2025).https://doi.org/10.3389/fnagi.2025.1520698
    Crossref
  2. Cognitive Activity From Early to Late Life and the Risk of AD Dementia, Neurology Open Access, 1, 1, (2025)./doi/10.1212/WN9.0000000000000002
    Abstract
  3. Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway, Journal of Alzheimer's Disease Reports, 9, (2025).https://doi.org/10.1177/25424823251315848
    Crossref
  4. Adaptation of the Florida Cognitive Activities Scale for Latinx adults with chronic diseases, Ethnicity & Health, 30, 3, (398-412), (2025).https://doi.org/10.1080/13557858.2025.2458306
    Crossref
  5. Cognitive reserve and its impact on cognitive and functional abilities, physical activity and quality of life following a diagnosis of dementia: longitudinal findings from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study, Age and Ageing, 54, 1, (2025).https://doi.org/10.1093/ageing/afae284
    Crossref
  6. Promoting Brain Health, These Three Things, (69-72), (2024).https://doi.org/10.1007/978-3-031-69394-6_9
    Crossref
  7. Causal relationships between dyslexia and the risk of eight dementias, Translational Psychiatry, 14, 1, (2024).https://doi.org/10.1038/s41398-024-03082-9
    Crossref
  8. Combined healthy lifestyle behaviours and incident dementia: A systematic review and dose–response meta-analysis of cohort studies, International Journal of Nursing Studies, 156, (104781), (2024).https://doi.org/10.1016/j.ijnurstu.2024.104781
    Crossref
  9. The Attributes and Characteristics of Leisure Activity Engagement that Foster Cognition in Aging: A Scoping Review, Journal of Cognitive Enhancement, 8, 1-2, (118-154), (2024).https://doi.org/10.1007/s41465-024-00286-1
    Crossref
  10. Public Libraries' Contribution to Sustainable Dementia-Friendly Communities, How Public Libraries Build Sustainable Communities in the 21st Century, (283-292), (2023).https://doi.org/10.1108/S0065-283020230000053026
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share